搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran ...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...
ENDPOINTS NEWS
7 天
FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO ...
Plus, news about Caliway Pharmaceuticals, argenx, Halozyme Therapeutics, Verrica, Liquidia and Pharmosa: FDA lifts partial clinical hold on Avidity Biosciences' drug: The treatment, called delpacibart ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Announces retirement
How to help Milton victims
Ethel Kennedy dies at 96
Inflation likely cooled again
Top colleges hit with lawsuit
AZ Senate debate takeaways
Files suit against accuser
To settle FTC charges
Approves elimination of NLI
Judge tosses New York law
Russian arms depot struck
Meat, poultry items recalled
Ex-AR deputy sentenced
Rare comet in October
To appear before trial judge
Increases heart attack risk?
Nobel Prize in literature
Jobless claims surge
US warns of solar storm
Tesla robotaxi launch
Idaho murder trial delayed
Ukraine meeting postponed
Faces $3B in penalties
Speaks with Netanyahu
$273M Helene relief bill
Georgia election board sued
反馈